EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cellular senescence: Neither irreversible nor reversible

Maurice Reimann iD, Soyoung Lee iD, Clemens A Schmitt iD

Journal of Experimental Medicine · 01.04.2024 · 221 (4)

DOI: 10.1084/jem.20232136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 22.02.2024. Verfasst von Maurice Reimann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Department of Hematology, Oncology and Tumor Immunology, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Be…. Hauptthemen laut MEDLINE: Cellular Senescence, Aging. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Krebshilfe, Deutsche Forschungsgemeinschaft, Förderverein Hämatologie und Internistische Onkologie (Tyle Private Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence is a critical stress response program implicated in embryonic development, wound healing, aging, and immunity, and it backs up apoptosis as an ultimate cell-cycle exit mechanism. In analogy to replicative exhaustion of telomere-eroded cells, premature types of senescence—referring to oncogene-, therapy-, or virus-induced senescence—are widely considered irreversible growth arrest states as well. We discuss here that entry into full-featured senescence is not necessarily a permanent endpoint, but dependent on essential maintenance components, potentially transient. Unlike a binary state switch, we view senescence with its extensive epigenomic reorganization, profound cytomorphological remodeling, and distinctive metabolic rewiring rather as a journey toward a full-featured arrest condition of variable strength and depth. Senescence-underlying maintenance-essential molecular mechanisms may allow cell-cycle reentry if not continuously provided. Importantly, senescent cells that resumed proliferation fundamentally differ from those that never entered senescence, and hence would not reflect a reversion but a dynamic progression to a post-senescent state that comes with distinct functional and clinically relevant ramifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceAgingFemalePregnancyHumansCell CycleCell DivisionApoptosis

Autor:innen und Institutionen

  • Medical Department of Hematology, Oncology and Tumor Immunology, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, and Molekulares Krebsforschungszentrum-MKFZ,…
  • Johannes Kepler University , Linz, Austria.
  • Department of Hematology and Oncology, Kepler University Hospital, Linz, Austria.
  • Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany.

ORCID-Profile: Maurice Reimann, Soyoung Lee, Clemens A Schmitt

Förderung

  • Deutsche Krebshilfe
  • Deutsche Forschungsgemeinschaft
  • Förderverein Hämatologie und Internistische Onkologie (Tyle Private Foundation)
  • German BMBF e:Med

Zitieren

APA

Reimann, M., Lee, S., & Schmitt, C. A. (2024). Cellular senescence: Neither irreversible nor reversible. Journal of Experimental Medicine, 221(4). https://doi.org/10.1084/jem.20232136

Vancouver

Reimann M, Lee S, Schmitt CA. Cellular senescence: Neither irreversible nor reversible. Journal of Experimental Medicine. 2024;221(4). doi:10.1084/jem.20232136

BibTeX
@article{Reimann2024,
  author = {Reimann, Maurice and Lee, Soyoung and Schmitt, Clemens A},
  title = {Cellular senescence: Neither irreversible nor reversible},
  journal = {Journal of Experimental Medicine},
  year = {2024},
  volume = {221},
  number = {4},
  doi = {10.1084/jem.20232136}
}
Kostenlos starten →